Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml
Synlett 2015; 26(18): 2521-2526
DOI: 10.1055/s-0035-1560657
DOI: 10.1055/s-0035-1560657
letter
Novel Method for the Synthesis of Substituted Imidazothiazolones
Further Information
Publication History
Received: 10 July 2015
Accepted after revision: 10 September 2015
Publication Date:
01 October 2015 (online)
Abstract
A general and highly selective method for the synthesis of 4-substituted 3a,6a-diphenyltetrahydro-2H-imidazo[4,5-d][1,3]thiazole-2,5(3H)-diones has been developed through a new reaction of 1-substituted 5-hydroxy-4,5-diphenyl-1Н-imidazol-2(5Н)-оnes with potassium thiocyanate in the presence of acetic acid in acetonitrile. Details of supramolecular organization in the crystalline imidazothiazolones, as revealed by X-ray diffraction, are highlighted.
Key words
cyclocondensations - potassium thiocyanate - heterocycles - polycycles - imidazolоnes - imidazothiazolesSupporting Information
- Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0035-1560657.
- Supporting Information
-
References and Notes
- 1 Ahmed R, Spikings E, Zhou S, Thompsett A, Zhang T. J. Immunol. Methods 2014; 406: 143
- 2a Kamburg R. US 20080227838, 2008 ; Chem. Abstr. 2008, 149, 347537
- 2b Ryzhkina IS, Kiseleva YV, Mishina OA, Timosheva AP, Sergeeva SY, Kravchenko AN, Konovalov AI. Mendeleev Commun. 2013; 23: 262
- 3 Langhammer S, Fiebig U, Kurth R, Denner J. Intervirology 2011; 54: 78
- 4a Hess C, Ritke N, Broecker S, Madea B, Musshoff F. Anal. Bioanal. Chem. 2013; 405: 4077
- 4b Hess C, Ritke N, Sydow K, Mehling L.-M, Ruehs H, Madea B, Musshoff F. Drug Test. Anal. 2014; 6: 1049
- 5a Moulin G, Cavalié P, Pellanne I, Chevance A, Laval A, Millemann Y, Colin P, Chauvin C. J. Antimicrob. Chemother. 2008; 62: 617
- 5b Peterson JW, Petrasky LJ, Seymour MD, Burkhart RS, Schuiling AB. Chemosphere 2012; 87: 911
- 6a Petersen H. Synthesis 1973; 243
- 6b Duspara PA, Matta CF, Jenkins SI, Harrison PH. M. Org. Lett. 2001; 3: 495
- 6c Schantl JG, Lagoja IM. Heterocycles 1998; 48: 929
- 7 Baranov VV, Kravchenko AN, Nelyubina YuV. Mendeleev Commun. 2014; 24: 105
- 8 Mobinikhaledi A, Amiri AK. J. Chem. Sci. (Berlin, Ger.) 2013; 125: 1055
- 9 Baranov VV, Antonova MM, Nelyubina YuV, Kolotyrkina NG, Zanin IE, Kravchenko AN. Mendeleev Commun. 2014; 24: 173
- 10a Antonova MM, Baranov VV, Nelyubina YuV, Kravchenko AN. Chem. Heterocycl. Compd. (Hoboken, NJ U. S.) 2014; 50: 503
- 10b Jasiński M, Mlostoń G, Mucha P, Linden A, Heimgartner H. Helv. Chim. Acta 2007; 90: 1765
- 11 Biltz H. Justus Liebigs Ann. Chem. 1909; 368: 156
- 12 1-Substituted 5-Hydroxy-4,5-diphenyl-1,5-dihydro-2H-imidazol-2-ones 8a–h; General Procedure 63% aq HNO3 (5 mL) was added dropwise to a suspension of the appropriate imidazolone 9a–h (4 mmol) in MeCN (25 mL). The reaction was monitored by the dissolution of the precipitated 9a–h and by the change in color of the solution. The mixture was then extracted with 1:1 CHCl3/H2O, the CHCl3 layer was evaporated, and the product was washed with Et2O. 5-Hydroxy-1-methyl-4,5-diphenyl-1,5-dihydro-2H-imidazol-2-one (8a) White powder; yield: 0.94 g (88%); mp 222–224 °С. 1H NMR (300 MHz, DMSO-d 6): δ = 2.55 (s, 3 H, Me), 7.25–7.48 (m, 7 H, Ph), 7.52–7.56 (m, 1 H, Ph), 7.75 (s, 1 H, OH), 8.01–8.04 (m, 2 H, Ph). 13C NMR (75 MHz, DMSO-d 6): δ = 23.82 (Me), 92.61 [С(Ph)OH], 125.18, 128.75, 128.83, 129.05, 129.60, 133.35, 136.61 (Ph), 163.44 (C=O), 186.39 (C=N). MS: m/z (%) = 266 (6) [M+], 250 (61), 180 (13), 163 (56), 135 (53), 134 (56), 118 (100). Anal. Calcd for C16H14N2O2: C, 72.16; H, 5.30; N, 10.52. Found: C, 72.07; H, 5.34; N 10.47. 1-Ethyl-5-hydroxy-4,5-diphenyl-1,5-dihydro-2H-imidazol-2-one (8b) White powder; yield: 0.91 g (81%); mp 214–216 °С. 1H NMR (300 MHz, DMSO-d 6): δ = 0.88 (t, J = 7.1 Hz, 3 H, Me), 2.87–3.04 (m, 1 H, СH2), 3.13–3.30 (m, 1 H, CH2), 7.25–7.50 (m, 7 H, Ph), 7.53–7.57 (m, 1 H, Ph), 7.73 (s, 1 H, OH), 7.99–8.02 (m, 2 H, Ph). 13C NMR (50 MHz, DMSO-d 6): δ = 13.79 (Me), 33.58 (CH2), 92.81 [С(Ph)OH], 125.20, 128.75, 128.82, 128.97, 129.65, 133.32, 137.32 (Ph), 163.38 (C=O), 186.07 (C=N). MS: m/z (%) = 280 (13) [M+], 252 (3), 208 (4), 177 (50), 165 (8), 148 (75), 134 (35), 105 (75), 91 (7), 77 (100). Anal. Calcd for C17H16N2O2: C, 72.84; H, 5.75; N, 9.99. Found: C, 72.79; H, 5.78; N, 10.06. 4-Substituted 3a,6a-Diphenyltetrahydro-2H-imidazo[4,5-d][1,3]thiazole-2,5(3H)-diones 13a–h; General Procedure AcOH (3.00 mL) was added to a solution of the appropriate imidazolone 8a–h (4 mmol) and KSCN (0.44 g, 4.5 mmol) in MeCN (17 mL) at r.t., and the mixture was refluxed for 1 h. The mixture was allowed to cool to r.t. and kept for 24 h to give a precipitate. (3aR*,6aR*)-4-Methyl-3a,6a-diphenyltetrahydro-2H-imidazo[4,5-d][1,3]thiazole-2,5(3H)-dione (13a) White powder; yield: 1.20 g (92%); mp >300 °С. 1H NMR (300 MHz, DMSO-d 6): δ = 2.64 (s, 3 H, Me), 6.85–6.98 (m, 2 H, Ph), 7.01–7.17 (m, 6 H, Ph), 7.18–7.28 (m, 2 H, Ph), 8.35 [s, 1 H, NH(NCO)], 9.72 [s, 1 H, NH(SCO)]. 13C NMR (75 MHz, DMSO-d 6): δ = 25.73 (Me), 83.19, 87.52 [(Ph)–C–C–(Ph)], 126.93, 127.49, 127.57, 128.07, 128.18, 128.71 (Ph), 132.92, 137.51 [C(Ph)], 158.38 [(N)C=O], 171.91 [(S)C=O]. HRMS: m/z [M + H]+ calcd for C17H16N3O2S: 326.0958; found: 326.0958. (3aR*,6aR*)-4-Ethyl-3a,6a-diphenyltetrahydro-2H-imidazo[4,5-d][1,3]thiazole-2,5(3H)-dione (13b) White powder; yield: 1.22 g (74%); mp 235–237 °С. 1H NMR (300 MHz, DMSO-d 6): δ = 1.12 (t, J = 7.0 Hz, 3 H, Me), 2.71–2.91 (m, 1 H, CH2), 3.31–3.50 (m, 1 H, CH2), 6.90–7.01 (m, 2 H, Ph), 7.02–7.19 (m, 6 H, Ph), 7.20–7.31 (m, 2 H, Ph), 8.20 [s, 1 H, NH(NCO)], 9.65 [s, 1 H, NH(SCO)]. 13C NMR (75 MHz, DMSO-d 6): δ = 14.80 (Me), 35.15 (CH2), 83.81, 87.80 [(Ph)–C–C–(Ph)], 126.95, 127.47, 127.51, 127.84, 128.14, 128.65 (Ph), 133.87, 137.49 [C(Ph)], 158.42 [(N)C=O], 172.27 [(S)C=O]. HRMS: m/z [M + H]+ calcd for C18H18N3O2S: 340.1114; found: 340.1110.